CoChat

The tolbutamide site of SUR1 and a mechanism for its functional coupling to KATP channel closure

Babenko, Andrey P, Gonzalez, Gabriela, Bryan, Joseph · 1999 · FEBS Letters

The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.

Abstract

Micromolar concentrations of tolbutamide will inhibit (SUR1/K IR 6.2)4 channels in pancreatic β‐cells, but not (SUR2A/K IR 6.2)4 channels in cardiomyocytes. Inhibition does not require Mg 2+ or nucleotides and is enhanced by intracellular nucleotides. Using chimeras between SUR1 and SUR2A, we show that transmembrane domains 12–17 (TMD12‐17) are required for high‐affinity tolbutamide inhibition of K ATP channels. Deletions demonstrate involvement of the cytoplasmic N‐terminus of K IR 6.2 in coupling sulfonylurea‐binding with SUR1 to the stabilization of an interburst closed configuration of the channel. The increased efficacy of tolbutamide by nucleotides results from an impairment of their stimulatory action on SUR1 which unmasks their inhibitory effects. The mechanism of inhibition of β‐cell K ATP channels by sulfonylureas during treatment of non‐insulin‐dependent diabetes mellitus thus involves two components, drug‐binding and conformational changes within SUR1 which are coupled to the pore subunit through its N‐terminus and the disruption of nucleotide‐dependent stimulatory effects of the regulatory subunit on the pore. These findings uncover a molecular basis for an inhibitory influence of SUR1, an ATP‐binding cassette (ABC) protein, on K IR 6.2, a ion channel subunit.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0014-5793(99)01215-6

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 46 references

Research works printed but not linked: 7

  1. Loubatieres M.M., 1992, Rev. Prat., 42, 2600
  2. Babenko A.P. Sharma N. Aguilar-Bryan L. Gonzalez G. and Bryan J. (1999) Diabetes (in press).
  3. Schwanstecher C., 1992, Mol. Pharmacol., 41, 480
  4. Babenko A.P., 1999, Biophys. J., 76, A14
  5. Aguilar-Bryan L. and Bryan J. (1999) in: Diabetes Mellitus (LeRoith D. Taylor S.I. and Olefsky J.M. Eds.) Lippencott-Raven Publishers Philadelphia (in press).
  6. Gopalakrishnan M., 1991, J. Pharmacol. Exp. Ther., 257, 1162
  7. Loussouarn G., 1999, Biophys. J., 76, A73

Cited by

See all 63

Metadata

Authors
Babenko, A. P., Gonzalez, G., & Bryan, J.
Affiliations
Baylor College of Medicine (US)
Corresponding author
Babenko, Andrey P
Venue
FEBS Letters
Publisher
Wiley
Published
1999-10-12
Volume
459
Issue
3
Pages
367-376
ISSN
  • 0014-5793 (ISSN-L)
  • 1873-3468
OpenAlex
W2058309943
Cited by
63
References
46
Citations by year
2023: 2 · 2019: 1 · 2018: 3 · 2017: 1 · 2016: 2 · 2015: 2 · 2014: 3 · 2013: 1 · 2012: 1
FWCI
1.26
Type
journal article
Language
en
Open access
closed
Locations
  • FEBS Letters (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › ATP Synthase and ATPases Research
Keywords
tolbutamide, SUR1, SUR2A, ATP-sensitive potassium channels, sulfonylurea receptor, Kir6.2, pancreatic beta cells, nucleotide inhibition, transmembrane domain, channel closure, ABC transporters, type 2 diabetes, chimeras
MeSH terms
Animals, Humans, Hypoglycemic Agents, Nucleotides, Receptors, Drug, Recombinant Fusion Proteins, Sulfonylurea Compounds, Tolbutamide, Potassium Channels, ATP-Binding Cassette Transporters, COS Cells, Potassium Channels, Inwardly Rectifying, Potassium Channel Blockers, Sulfonylurea Receptors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The tolbutamide site of SUR1 and a mechanism for its functional coupling to KATP channel closure. https://app.cochat.ai/papers/10.1016/s0014-5793(99)01215-6
The paper
Babenko, A. P., Gonzalez, G., & Bryan, J. (1999). The tolbutamide site of SUR1 and a mechanism for its functional coupling to KATP channel closure. FEBS Letters. https://doi.org/10.1016/s0014-5793(99)01215-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.